U.S. Life Sciences Stock News

S&P Global (SPGI) has just wrapped up 2025 with fourth quarter revenue of US$3.9b and basic EPS of US$3.76, setting the stage for its Q1 2026 update against a backdrop of rising trailing twelve month revenue and earnings. Over the last six reported quarters, revenue has moved from US$3.6b in Q3 2024 to US$3.9b in Q4 2025 while quarterly basic EPS has ranged from US$2.85 to US$3.86. This has contributed to trailing twelve month EPS of US$14.67 and revenue of US$15.3b by the end of 2025. With a...

Applied Industrial Technologies (AIT) heads into its Q3 2026 update with a recent track record that has revenue moving from US$1,073.0 million in Q2 2025 to US$1,163.0 million in Q2 2026, while basic EPS has shifted from US$2.43 to US$2.54 over the same period, alongside trailing 12 month earnings growth of 4.6%. Over the last year, total revenue on a trailing basis has gone from US$4.48 billion to US$4.75 billion, with trailing EPS ticking from US$10.02 to US$10.65 as net profit margin holds...

If you are wondering whether Atlanticus Holdings at around US$79.39 still offers value, you are in the right place to assess what that price might actually represent. The stock has had a strong run, with recent total returns of 8.8% over 7 days, 50.6% over 30 days, 19.7% year to date, 42.7% over 1 year, 177.7% over 3 years and 151.3% over 5 years. These moves have come alongside ongoing attention on Atlanticus Holdings within the Consumer Finance space, as investors weigh how its business...

Genuine Parts (NYSE:GPC) has rolled out Manhattan Active Warehouse Management at its Brisbane distribution centre. The new system replaces legacy platforms and manual workflows across the facility. The move forms part of a wider supply chain modernization effort following recent board changes and activist involvement. For a company built around auto and industrial parts distribution, the way Genuine Parts moves inventory is central to its business model. This shift to a modern warehouse...

Everforth, Inc. ( NYSE:EFOR ) shareholders (or potential shareholders) will be happy to see that the CEO & Director...

The United States market remained flat over the last week but has experienced a significant 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking potential gains while aligning with projected growth trends.

In the last week, the market has stayed flat, yet it is up 30% over the past year with earnings forecast to grow by 16% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability within a rapidly evolving sector.

The United States market remained flat over the last week but has seen a notable 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.

In the last week, the U.S. market has stayed flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% per annum in the coming years. Amidst these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors looking to capitalize on market opportunities. Penny stocks may be an outdated term, but they still represent a valuable investment area; when backed by strong financials and balance sheet strength, these smaller...

The United States market has experienced a flat performance over the last week but has seen a significant 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that combine strong fundamentals and growth potential can be key to uncovering hidden opportunities in the market.

Relay Therapeutics scheduled a special call to present new clinical data on its Zovegalisib triplet therapy in breast cancer. The company plans to discuss the combination treatment results and their implications for its development programs. The announcement focuses on Zovegalisib in a triplet regimen, which may be relevant for investors following Relay Therapeutics drug pipeline. Relay Therapeutics, listed as NasdaqGM:RLAY, is drawing attention with a dedicated update on Zovegalisib, a key...

Investors may be wondering if Popular at around US$150.62 is still offering value after a strong run, or if most of the easy gains are already on the table. The stock has returned 1.4% over the last 7 days, 15.8% over the past month, 19.6% year to date, 59.5% over 1 year, 188.1% over 3 years and 128.7% over 5 years, which can change how the market views both its potential and its risks. Recent coverage has focused on Popular's position within the US banking sector and how investors are...

If you are wondering whether Marex Group's current share price reflects its true worth, this article walks through the key numbers that matter for value focused investors. The stock recently closed at US$53.12, with returns of 7.4% over 7 days, 23.6% over 30 days, 40.0% year to date, and 20.8% over 1 year. These figures put recent price moves front and center in any valuation discussion. Recent coverage has focused on Marex Group as a listed player in the capital markets space and on how its...

Teledyne Technologies Incorporated ( NYSE:TDY ) investors will be delighted, with the company turning in some strong...

Wondering if STAG Industrial is offering fair value at around US$39.48, or if the current price is leaving something on the table for new investors. The stock has had a mixed run recently, with a 1% decline over the last 7 days, a 9.4% gain over the last 30 days, and returns of 6.9% year to date and 25.3% over the last year. Recent coverage has focused on STAG Industrial's position in the industrial real estate space and how investors are weighing it against wider REIT options. This context...

In April 2026, Equity LifeStyle Properties, Inc. reported first-quarter 2026 results showing revenue of US$397.62 million, up from US$387.33 million a year earlier, while net income eased to US$107.9 million from US$109.19 million, and issued net income per share guidance of US$0.42–US$0.48 for the second quarter and US$2.02–US$2.12 for full-year 2026. The combination of higher revenue but slightly lower net income, alongside detailed earnings guidance, gives investors fresh insight into how...

Blue Owl Real Estate Capital has agreed to acquire Sila Realty Trust (NYSE:SILA) in an all cash merger valued at about $1.7 billion. The transaction has been unanimously approved by Sila’s board and will proceed to a shareholder vote. The deal would end Sila’s run as an independent, publicly traded, healthcare-focused real estate company. Sila Realty Trust enters this deal with its shares at $30.42 and a value score of 2, along with a 20.3% return over 5 years. More recently, the stock...

The United States market has shown a remarkable 30% increase over the past year, despite remaining flat over the last week, with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are perceived as undervalued and exhibit insider buying can be an attractive strategy for investors seeking opportunities in a dynamic market environment.

The United States market has remained flat over the last week but is up 30% over the past year, with earnings forecast to grow by 16% annually. In this environment, identifying high-growth tech stocks that demonstrate strong potential for innovation and scalability can be crucial for investors looking to capitalize on these favorable conditions.

Over the last 7 days, the United States market has remained flat, yet it is up 30% over the past year with earnings expected to grow by 16% per annum in the coming years. In this environment, identifying stocks that may be trading at an estimated discount can provide opportunities for investors seeking value amidst a generally rising market.

Wondering whether JinkoSolar Holding at around US$22.27 is pricing in too much risk or not enough potential? This article breaks down what the current share price might actually reflect. The stock has been volatile recently, with a 3.7% gain over the last week, an 11.9% decline over the last month, a 20.3% decline year to date, and a 34.1% return over the past year, on top of weaker 3 year and 5 year returns of 46.2% and 27.6% respectively. Recent coverage has focused on JinkoSolar Holding...

Wondering if Manchester United shares are offering fair value or just trading on the club's global brand? This article breaks down what the current price might really be telling you. The stock last closed at US$17.22, with a 7 day return of a 3.8% decline, a 30 day return of 5.3%, a year to date return of 9.1% and a 1 year return of 24.2%. The 3 year and 5 year returns stand at a 10.0% decline and 0.5% respectively. Recent headlines around ownership, governance and the club's on field...

We can readily understand why investors are attracted to unprofitable companies. Indeed, Tenax Therapeutics...

Wondering if Deluxe at around US$30.50 is offering real value or if the big move has already happened? This article walks through what the current price is actually saying about the stock. Over the short term the share price has been fairly mixed, with a 0.2% decline over 7 days, a 13.0% gain over 30 days and a year to date return of 37.4%, while the 1 year return sits at 110.4% and the 3 year return at 146.6%, compared with a 5 year return of an 11.0% decline. Recent coverage has focused on...